Right now the market is feeling pressure from tariffs, earnings and valuations all at once and honestly this time the earnings have not impressed as much as they should have.
All the investors who had taken positions in pharma and hospital stocks solely based on COVID, I think they will start selling very soon, because COVID is not spreading as rapidly as expected, and the revenue expectations have returned to normal.
